Vaccine Dosing Considerations in Product Labels and ACIP Recommendations: A Review

Area of Science:

• Immunology
• Public Health
• Regulatory Science

Background:

• The Food and Drug Administration (FDA) approves vaccines based on safety, efficacy, and benefit/risk.
• The Advisory Committee on Immunization Practices (ACIP) provides recommendations for vaccine use and schedules.
• CDC national immunization schedules are influenced by ACIP recommendations.

Purpose of the Study:

• To examine historical discrepancies between FDA-approved vaccine dosing and ACIP recommendations.
• To identify the frequency and reasons for these dosing differences.
• To inform future ACIP recommendations for vaccine schedules.

Main Methods:

• Analysis of 78 vaccines for deviations between FDA labeling and ACIP recommendations.
• Categorization of identified deviations (e.g., additive, reductive).

Main Results:

• Only 5 out of 78 assessed vaccines showed deviations from FDA labeling.
• One vaccine exhibited a reduced dosing schedule.
• Most deviations were additive, not reductive.

Conclusions:

• Differences between FDA-approved vaccine dosing and ACIP recommendations are infrequent.
• Additive deviations are more common than reductive ones.
• Findings suggest a rare occurrence of dosing discrepancies in vaccine recommendations.